Skip to main content

Breadcrumb

  1. Home

Payment Program

Valid for Measure Submission
Valid for Initial Endorsement
Valid for Maintenance

Clinician-Level and Clinician Group-Level Total Hip Arthroplasty and/or Total Knee Arthroplasty (THA and TKA) Patient-Reported Outcome-Based Performance Measure (PRO-PM)

  • This patient-reported outcome-based performance measure uses the same measure specifications as the NQF-endorsed (NQF # 3559) hospital-level risk-standardized improvement rate (RSIR) following elective primary THA/TKA with the following exception: this measure attributes the outcome to a clinician or clinician group. Specifically, this measure will estimate a clinician-level and/or a clinician group-level RSIR following elective primary THA/TKA for Medicare fee-for-service (FFS) patients 65 years of age and older.

    CBE ID
    3639

CollaboRATE Shared Decision Making Score

  • CollaboRATE is a patient-reported measure of shared decision making which contains three brief questions that patients, their parents, or their representatives complete following a clinical encounter. The CollaboRATE measure provides a performance score representing the percentage of adults 18 and older who experience a high level of shared decision making.

    CBE ID
    3227

Composite weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single

  • Measure title continued: Composite weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan)

    CBE ID
    3621

Comprehensive Diabetes Care

  • The percentage of patients 18–75 years of age with diabetes (type 1 and type 2) who had each of the following:
    - Hemoglobin A1c (HbA1c) testing (NQF#0057)
    - HbA1c poor control (>9.0%) (NQF#0059)
    - HbA1c control (<8.0%) (NQF#0575)
    - HbA1c control (<7.0%) for a selected population*
    - Eye exam (retinal) performed (NQF#0055)
    - LDL-C screening (NQF#0063)
    - LDL-C control (<100 mg/dL) (NQF#0064)
    - Medical attention for nephropathy (NQF#0062)
    - BP control (<140/90 mm Hg) (NQF#0061)
    - Smoking status and cessation advice or treatment

    CBE ID
    0731